We are live on
!
Find out more
CS
Credit Suisse Portfolio holdings
AUM
$104B
1-Year Est. Return
34.76%
This Fund
S&P 500
This Quarter
Est. Return
-11.88%
1 Year Est. Return
+34.76%
3 Year Est. Return
+49.35%
5 Year Est. Return
+181.01%
10 Year Est. Return
+395.52%
AUM
$96.1B
AUM Growth
-$15.5B
(-14%)
Cap. Flow
+$483M
Cap. Flow
% of AUM
0.5%
Top 10 Holdings %
Top 10 Hldgs %
15.04%
Holding
4,137
New
391
Increased
1,950
Reduced
1,291
Closed
279
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
VanEck Gold Miners ETF
GDX
|
+$385M |
| 2 |
VanEck Junior Gold Miners ETF
GDXJ
|
+$370M |
| 3 |
Linde
LIN
|
+$309M |
| 4 |
iShares MSCI Brazil ETF
EWZ
|
+$231M |
| 5 |
Alibaba
BABA
|
+$214M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$1.57B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1B |
| 3 |
Thomson Reuters
TRI
|
+$802M |
| 4 |
UGAZ
VelocityShares 3x Long Natural Gas ETN linked to the S&P GSCI Natural Gas Index ER due February 9, 2
UGAZ
|
+$312M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$266M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 11.03% |
| 2 | Technology | 10.74% |
| 3 | Healthcare | 9.35% |
| 4 | Industrials | 6.72% |
| 5 | Consumer Discretionary | 6.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3326
Q32 Bio
QTTB
$466M
| $358K | ﹤0.01% |
+890
| New | +$337K |
|
3327
Assembly Biosciences
ASMB
$498M
| $356K | ﹤0.01% |
1,310
+183
| +16% | +$52.9K |
|
3328
Financial Institutions
FISI
$816M
| $356K | ﹤0.01% |
13,877
+1,148
| +9% | +$32.6K |
|
3329
iShares US Home Construction ETF
ITB
$2.26B
| $356K | ﹤0.01% |
11,867
+627
| +6% | +$19.7K |
|
3330
Wave Life Sciences
WVE
$1.09B
| $356K | ﹤0.01% |
8,463
+1,651
| +24% | +$73.4K |
|
|
AUD
3331
DELISTED
Audacy, Inc.
AUD
| $356K | ﹤0.01% |
62,351
+23,637
| +61% | +$157K |
|
|
APU
3332
DELISTED
AmeriGas Partners, L.P.
APU
| $355K | ﹤0.01% |
14,027
+1,547
| +12% | +$53.7K |
|
|
QADA
3333
DELISTED
QAD Inc.
QADA
| $355K | ﹤0.01% |
9,024
-1,361
| -13% | -$59.5K |
|
|
LDL
3334
DELISTED
Lydall, Inc.
LDL
| $354K | ﹤0.01% |
17,399
+4,419
| +34% | +$121K |
|
|
BFYT
3335
DELISTED
Benefytt Technologies, Inc. Class A Common Stock
BFYT
| $354K | ﹤0.01% |
+13,222
| New | +$530K |
|
|
CIR
3336
DELISTED
CIRCOR International, Inc
CIR
| $353K | ﹤0.01% |
16,611
+2,913
| +21% | +$96.8K |
|
3337
Fidelity MSCI Industrials Index ETF
FIDU
$2.3B
| $352K | ﹤0.01% |
+10,743
| New | +$388K |
|
|
CAMP
3338
DELISTED
CalAmp Corp.
CAMP
| $351K | ﹤0.01% |
1,171
+198
| +20% | +$82.2K |
|
3339
Cerus
CERS
$433M
| $350K | ﹤0.01% |
69,182
-18,669
| -21% | -$108K |
|
|
HUD
3340
DELISTED
Hudson Ltd. Class A Common Shares
HUD
| $350K | ﹤0.01% |
20,369
-2,386
| -10% | -$46.9K |
|
3341
Clearwater Paper
CLW
$339M
| $349K | ﹤0.01% |
14,309
+2,262
| +19% | +$61K |
|
3342
Team
TISI
$79.5M
| $349K | ﹤0.01% |
2,376
+290
| +14% | +$52.9K |
|
|
SUPV
3343
Grupo Supervielle
SUPV
$828M
| $347K | ﹤0.01% |
+40,000
| New | +$325K |
|
3344
iShare MSCI Eurozone ETF
EZU
$9.64B
| $346K | ﹤0.01% |
+9,901
| New | +$370K |
|
3345
ANI Pharmaceuticals
ANIP
$1.8B
| $344K | ﹤0.01% |
7,657
+1,591
| +26% | +$83.4K |
|
|
TVRD
3346
Tvardi Therapeutics
TVRD
$19.7M
| $343K | ﹤0.01% |
734
+231
| +46% | +$149K |
|
|
NS
3347
DELISTED
NuStar Energy L.P.
NS
| $341K | ﹤0.01% |
16,307
-185,277
| -92% | -$4.53M |
|
|
ANCX
3348
DELISTED
Access National Corp
ANCX
| $341K | ﹤0.01% |
+15,986
| New | +$404K |
|
3349
York Water
YORW
$502M
| $340K | ﹤0.01% |
10,650
+1,753
| +20% | +$56.2K |
|
3350
Equinor
EQNR
$97.7B
| $339K | ﹤0.01% |
16,000
+6,000
| +60% | +$147K |
|
Similar funds
CSIA
CAN
VAM
CA
MNG
DPAM
ICG
CW
Credit Suisse's Q4 2018 Portfolio in Review
As of Q4 2018, Credit Suisse held 4,137 positions worth $96.1B, down 14% from $112B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Credit Suisse's Q4 2018 filing shows 391 new, 1,950 increased, 1,291 reduced and 279 closed positions. Its largest new stake was Linde: 1,955,783 shares worth $305M. The largest sale was UnitedHealth, an estimated $1.57B.
By sector, the portfolio is most concentrated in Financials at 11% of assets, up from 10% a quarter earlier, followed by Technology and Healthcare.
- Credit Suisse's largest Q4 2018 buy was Linde: 1,955,783 shares worth $305M.
- Credit Suisse added most to VanEck Gold Miners ETF in Q4 2018, an estimated $385M increase.
- Credit Suisse's biggest Q4 2018 reduction was UnitedHealth, cutting an estimated $1.57B.
- Credit Suisse fully exited Grifois in Q4 2018, selling an estimated $190M.
- Credit Suisse's ten largest holdings make up 15% of its $96.1B portfolio in Q4 2018.
- Credit Suisse opened 391 new positions and closed 279 in Q4 2018.
- Credit Suisse's portfolio value fell 14% quarter-over-quarter to $96.1B.
Based on Credit Suisse's 13F filing for Q4 2018, filed 13 Feb 2019.